GE HealthCare Technologies Inc. (GEHC)

Market Cap	38.79B
Revenue (ttm)	19.56B
Net Income (ttm)	1.68B
Shares Out	456.87M
EPS (ttm)	3.65
PE Ratio	23.26
Forward PE	18.72
Dividend	$0.12 (0.14%)
Ex-Dividend Date	Oct 18, 2024

Volume	5,155,646
Open	82.50
Previous Close	82.52
Day's Range	82.41 - 85.29
52-Week Range	66.39 - 94.55
Beta	n/a
Analysts	Buy
Price Target	94.36 (+11.14%)
Earnings Date	Oct 30, 2024

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health p...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1892
• Employees: 51,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2023, GEHC's revenue was $19.55 billion, an increase of 6.60% compared to the previous year's $18.34 billion. Earnings were $1.39 billion, a decrease of -27.71%.

Analyst Forecast

According to 14 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $94.36, which is an increase of 11.14% from the latest price.

Price Target

$94.36

(11.14% upside)

Analyst Consensus: Buy